AXIM raises $1.825M in new debt; retires $1.11M GS Capital note

AXIM BIOTECHNOLOGIES, INC.

Issued two $250K short-term notes (1.5% interest, due March 10, 2022); one repaid on Feb 14.
Issued seven convertible notes aggregate $1.325M at 3% interest, due 2032; conversion at 70% of avg two lowest closing prices.
One $25K convertible note was acquired by director Blake N. Schroeder.
Repaid GS Capital Partners note ($1.11M face) in full; accrued interest $21,876 paid via 173,390 restricted shares.

item 1.01 item 1.02 item 2.03 item 3.02 item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.